Customers We Serve

Supporting every stage of bioprocessing innovation

Across the bioprocessing industry, Thermo Fisher Scientific helps biopharma, biotech, and CDMO organizations improve productivity and reliability in bioprocessing development. We connect science and scale through integrated, cGMP-ready solutions that simplify complex workflows, improve consistency, and accelerate progress from research to manufacturing. By aligning technologies, services, and solutions, and drawing on more than 60 years of experience, we support improved performance, reduce risk, and move therapies efficiently from molecule to medicine. 
 

Biopharma

Bioprocessing solutions enable biopharma teams to enhance efficiency, maintain quality, and mitigate risk throughout cGMP production.

Biotech

Comprehensive bioprocessing services and technical support help organizations optimize workflows and scale development processes.

CDMO

Integrated bioprocessing solutions enable CDMOs to maintain consistency, support technology transfer, and scale efficiently.
 

Supporting diverse modalities and applications

Thermo Fisher Scientific strengthens productivity across bioprocessing workflows, helping to accelerate development, increase product yield, and enhance sustainability. Our connected, scalable solutions empower the companies we serve to maintain consistency and efficiency from early-stage development through production. Designed to reduce risk and maximize resource use, our portfolio enables fast, reliable outcomes across bioprocessing modalities from antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) to cell and gene therapies, messenger RNA (mRNA), and vaccines.

Antibody-drug conjugates (ADCs)

Integrated bioprocessing workflows simplify ADC development and enhance productivity and reliability from research to manufacturing.

Cell Therapy

Maintain product integrity while optimizing efficiency from bench to bedside with end-to-end, closed systems.
 

Gene Therapy

Modular, scalable solutions help gene therapy developers promote consistent quality and easy scale-up, contributing to risk reduction across workflows.

Monoclonal antibodies (mAbs)

Our advanced portfolio supports high-yield, scalable mAb production with robust process control, helping reduce manufacturing risk.

Messenger RNA (mRNA)

Advanced technologies support rapid development cycles and manufacturing, enabling reliable delivery of high-quality mRNA therapies.

Vaccines

Accelerate vaccine development with workflows that drive consistency and sustainability to meet global health demands efficiently.

Sustainability and innovation by design


At Thermo Fisher Scientific, we are committed to helping our customers achieve sustainability in their workflows. Environmental responsibility is integrated into various stages of bioprocessing, enabling organizations to reduce their environmental impact while maintaining workflow integrity and performance. Through resource-efficient design, innovative material use, and energy-conscious operations, we support teams in making measurable progress toward sustainability goals without adding complexity to their processes.

Bioprocessing resources


Access a range of resources designed to deepen your bioprocessing knowledge. Explore case studies, application notes, and on-demand webinars for valuable insights into emerging technologies, process optimizations, and productivity enhancements in biologics and advanced therapies.

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.